Skip to main content
. 2019 Nov 13;11:683–694. doi: 10.2147/CEOR.S222879

Figure 2.

Figure 2

Univariate sensitivity analysis. a. Based on economic evaluation guidelines. b. Based on NICE recommendations. c. In keeping with the follow-up time in the RATIFY study. d. The highest cost of allogeneic HSCT found in the available evidence (eSalud). e. Cost of HSCT equivalent to the cost of DRG 803 (“Allogenic bone marrow transplantation”). f. Based on expert opinion.

Abbreviations: AE, adverse events; PVL, ex-factory price.